• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOLTON MEDICAL, INC. RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM; STENT, ENDOVASCULAR GRAFT, AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOLTON MEDICAL, INC. RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM; STENT, ENDOVASCULAR GRAFT, AORTIC Back to Search Results
Catalog Number 28-NC36N07030S2490
Device Problems Failure to Advance (2524); Component or Accessory Incompatibility (2897)
Patient Problem Insufficient Information (4580)
Event Date 01/27/2022
Event Type  malfunction  
Event Description
We have a question regarding the eligibility of patient 014-026-zzz.He did not receive a terumo device due to complications during the procedure.The patient was supposed to receive a custom relay device on (b)(6) 2022.The device was unable to pass through an existing evar device.The left axillary artery was explored for bodyfloss, during which the patient became hypotensive due to bleeding in the external iliac artery.The bleeding was stopped using two excl uders and one viabahn stent.The relay device was not placed.After the surgery, another attempt was deemed not possible.The patient will therefore not be receiving a terumo device.There was uncertainty whether or not the patient should remain in the tiger study.On the one hand, no terumo device was or will be placed.On the other, the patient did meet all inclusion criteria and an attempt was made to place a terumo device, albeit unsuccessful.Not including the patient may paint a distorted picture of the risks of intervention, whether this was caused by the device or not.If the patient ought to remain in the study, we shall provide all relevant information regarding the intervention and follow-ups, and further follow-ups will continue to be planned for the tiger study.If the patient is deemed to be a screening failure, we shall act accordingly.Patient outcome - unknown.
 
Manufacturer Narrative
Bolton medical is voluntarily reporting an event related to a relay plus custom-made device.The custom made relay plus device is not marketed in the us.However; it is similar to the relay plus thoracic stent graft system approved for sale in the us (p110038).The event occurred in the netherlands.
 
Event Description
We have a question regarding the eligibility of patient (b)(6).He did not receive a terumo device due to complications during the procedure.The patient was supposed to receive a custom relay device on 27-1-2022.The device was unable to pass through an existing evar device.The left axillary artery was explored for bodyfloss, during which the patient became hypotensive due to bleeding in the external iliac artery.The bleeding was stopped using two excl uders and one viabahn stent.The relay device was not placed.After the surgery, another attempt was deemed not possible.The patient will therefore not be receiving a terumo device.There was uncertainty whether or not the patient should remain in the tiger study.On the one hand, no terumo device was or will be placed.On the other, the patient did meet all inclusion criteria and an attempt was made to place a terumo device, albeit unsuccessful.Not including the patient may paint a distorted picture of the risks of intervention, whether this was caused by the device or not.If the patient ought to remain in the study, we shall provide all relevant information regarding the intervention and follow-ups, and further follow-ups will continue to be planned for the tiger study.If the patient is deemed to be a screening failure, we shall act accordingly.Patient outcome - "unknown.".
 
Manufacturer Narrative
Bolton medical is voluntarily reporting an event related to a relay plus custom-made device.The custom made relay plus device is not marketed in the us, however it is similar to the relay thoracic stent graft with plus delivery system approved for sale in the us (p110038).The event occurred in the netherlands.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM
Type of Device
STENT, ENDOVASCULAR GRAFT, AORTIC
Manufacturer (Section D)
BOLTON MEDICAL, INC.
799 international parkway
sunrise FL 33325
Manufacturer Contact
megan indeglia
799 international parkway
sunrise, FL 33325
9548389699
MDR Report Key14593805
MDR Text Key301035661
Report Number2247858-2022-00082
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
P110038
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 07/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/06/2022
Device Catalogue Number28-NC36N07030S2490
Device Lot Number2112290084
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 05/13/2022
Initial Date FDA Received06/03/2022
Supplement Dates Manufacturer Received05/13/2022
Supplement Dates FDA Received07/07/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/07/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age99 YR
-
-